AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well AZD0530 works in treating patients with recurrent
locally advanced, or metastatic soft tissue sarcoma. AZD0530 may stop the growth of tumor
cells by blocking some of the enzymes needed for cell growth.